Evidence map›Paper›PMID 28986464›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

A Role of Endogenous Progesterone in Stroke Cerebroprotection Revealed by the Neural-Specific Deletion of Its Intracellular Receptors.

Xiaoyan Zhu, Magalie Fréchou, Philippe Liere, Shaodong Zhang, Antoine Pianos, Neïké Fernandez, Christian Denier, Claudia Mattern, Michael Schumacher, Rachida Guennoun

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Xiaoyan ZhuU1195 Inserm and University Paris-Sud and University Paris-Saclay, 94276 Kremlin-Bicêtre, France.
Magalie FréchouU1195 Inserm and University Paris-Sud and University Paris-Saclay, 94276 Kremlin-Bicêtre, France.
Philippe LiereU1195 Inserm and University Paris-Sud and University Paris-Saclay, 94276 Kremlin-Bicêtre, France.
Shaodong ZhangU1195 Inserm and University Paris-Sud and University Paris-Saclay, 94276 Kremlin-Bicêtre, France.
Antoine PianosU1195 Inserm and University Paris-Sud and University Paris-Saclay, 94276 Kremlin-Bicêtre, France.
Neïké FernandezU1195 Inserm and University Paris-Sud and University Paris-Saclay, 94276 Kremlin-Bicêtre, France.ORCID 0000-0001-9127-248X
Christian DenierU1195 Inserm and University Paris-Sud and University Paris-Saclay, 94276 Kremlin-Bicêtre, France.
Claudia MatternMetP Pharma AG, 6376 Emmetten, Switzerland.
Michael SchumacherU1195 Inserm and University Paris-Sud and University Paris-Saclay, 94276 Kremlin-Bicêtre, France, rachida.guennoun@inserm.fr michael.schumacher@inserm.fr.
Rachida GuennounU1195 Inserm and University Paris-Sud and University Paris-Saclay, 94276 Kremlin-Bicêtre, France, rachida.guennoun@inserm.fr michael.schumacher@inserm.fr.ORCID 0000-0002-9219-7300
Inserm · FRVifor Pharma (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment with progesterone protects the male and female brain against damage after middle cerebral artery occlusion (MCAO). However, in both sexes, the brain contains significant amounts of endogenous progesterone. It is not known whether endogenously produced progesterone enhances the resistance of the brain to ischemic insult. Here, we used steroid profiling by gas chromatography-tandem mass spectrometry (GC-MS/MS) for exploring adaptive and sex-specific changes in brain levels of progesterone and its metabolites after MCAO. We show that, in the male mouse brain, progesterone is mainly metabolized via 5α-reduction leading to 5α-dihydroprogesterone (5α-DHP), also a progesterone receptor (PR) agonist ligand in neural cells, then to 3α,5α-tetrahydroprogesterone (3α,5α-THP). In the female mouse brain, levels of 5α-DHP and 3α,5α-THP are lower and levels of 20α-DHP are higher than in males. After MCAO, levels of progesterone and 5α-DHP are upregulated rapidly to pregnancy-like levels in the male but not in the female brain. To assess whether endogenous progesterone and 5α-DHP contribute to the resistance of neural cells to ischemic damage, we inactivated PR selectively in the CNS. Deletion of PR in the brain reduced its resistance to MCAO, resulting in increased infarct volumes and neurological deficits in both sexes. Importantly, endogenous PR ligands continue to protect the brain of aging mice. These results uncover the unexpected importance of endogenous progesterone and its metabolites in cerebroprotection. They also reveal that the female reproductive hormone progesterone is an endogenous cerebroprotective neurosteroid in both sexes.

Indexed as

NeuronsAgingAnimalsBrain ChemistryFemaleGene DeletionInfarction, Middle Cerebral ArteryMaleMiceMice, Inbred C57BLNeuroprotective AgentsPregnenoloneProgesteroneReceptors, ProgesteroneSex CharacteristicsStrokeNeuroprotective AgentsPregnenoloneProgesteroneReceptors, Progesteroneagingendogenousneuroprotectionprogesterone receptorssex differencessteroids

Identifiers

PMID28986464
PMCPMC6596486
OpenAlexW2763727762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.